Linked Data API

Show Search Form

Search Results

1134013
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hospitals: Listeria Monocytogenes more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent listeria in food in hospitals. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268501 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>On 17 June 2019, my Rt. hon. Friend the Secretary of State for Health and Social Care announced a root-and-branch review of all the food in hospitals, both food served, and food sold. This will look at the safety of food available to patients, visitors and staff, and provide healthier choices and improved nutrition.</p><p>National Health Service organisations have systems of due diligence in place to ensure that all their suppliers have appropriate registrations. The kitchens and other areas in the NHS used to store and process food are required to be registered and rated by the local authority and all staff involved in the preparation and handling of food are required to hold a level two food hygiene certificate. In addition to this, a food safety management system must be in place that outlines controls and processes for the safe delivery, handling and preparing of foods.</p><p>The Food Standards Agency (FSA) published comprehensive guidance for healthcare and social care organisations on managing listeria risk in vulnerable people in 2016. The FSA commissioned delivery of training to 557 key staff responsible for food safety in hospitals and 288 local authority Environmental Health Officers in a series of workshops and webinars in 2015.</p><p><strong> </strong></p>
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-07-02T16:26:38.22Zmore like thismore than 2019-07-02T16:26:38.22Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134014
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Heart Diseases: Young People more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent heart disease in young people aged 17-30. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268502 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>The NHS Long Term Plan advises that cardiovascular disease (CVD) is largely preventable, through lifestyle changes and a combination of public health and National Health Service action on smoking and tobacco addiction, obesity, tackling alcohol misuse and food reformulation.</p><p>A key milestone in the CVD section of the NHS Long Term Plan is for the National Health Service to help prevent up to 150,000 heart attacks, strokes and dementia cases over the next 10 years. The NHS Long Term Plan sets out that where individuals are identified with high risk conditions, appropriate preventative treatments will be offered in a timely way, and the creation of a national CVD prevention audit for primary care will also support continuous clinical improvement. NHS England and NHS Improvement will continue to work closely with key partners and stakeholders, such as the British Heart Foundation, as it supports the NHS to deliver the commitments set out in the NHS Long Term Plan.</p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-07-02T16:31:43.143Zmore like thismore than 2019-07-02T16:31:43.143Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134015
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Health Services: Armed Forces more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that wounded soldier health and rehabilitation bills are paid for by the NHS. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268503 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>Veterans are able to receive care through all NHS services and are also able to receive priority treatment for conditions relating to their service. In addition to mainstream services, Veterans can also access specific services such as the Veterans Trauma Network. Veterans are able to access high quality clinically appropriate prosthetic limbs from the National Health Service. Nine NHS prosthetic centres are in place to provide enhanced services for veterans.</p><p>In addition to these services, a new package of support for seriously wounded armed forces personnel was launched on 29 March 2019, the Integrated Personal Commissioning for Veterans Framework (IPC4V). This new pathway will ensure that individuals with very complex and enduring healthcare requirements transitioning out of the military into civilian life will continue to receive comprehensive support.</p><p>The above services (as well as some for mental health needs) are commissioned and paid for by NHS England, whereas the devolved administrations have their own arrangements for providing care to veterans.</p><p>The health needs of serving personnel are dealt with by the Defence Medical Services.</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2019-07-02T15:03:08.157Zmore like thismore than 2019-07-02T15:03:08.157Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134016
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Arthritis: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, when electrical stimulation for arthritis pain will be available on the NHS. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268504 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>We are aware of recent research looking at electrical stimulation of the vagus nerve to treat patients with rheumatoid arthritis. This was a small pilot study of 14 people, and therefore research remains at an early stage. In order to be suitable for routine National Health Service use, larger scale clinical trials demonstrating the safety and efficacy of this treatment approach would need to be undertaken, and assessments of its cost effectiveness would also need to be considered.</p> more like this
answering member constituency South Ribble more like this
answering member printed Seema Kennedy more like this
question first answered
less than 2019-07-02T16:34:30.03Zmore like thismore than 2019-07-02T16:34:30.03Z
answering member
4455
label Biography information for Seema Kennedy more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134018
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will list the (a) criteria and (b) timelines for products to be considered in (i) the current round and (ii) future review rounds of the Accelerated Access Collaborative route. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268506 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
question first answered
less than 2019-07-02T16:12:14.213Zmore like thismore than 2019-07-02T16:12:14.213Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134019
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how products selected by the Accelerated Access Collaborative will be funded. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268507 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>As announced in the Life Sciences Sector Deal 2, up to £2 million of Pathway Transformation Funding has been made available to support the use and integration of product selected by the Accelerated Access Collaborative (AAC) into every day practice within the National Health Service. In addition, four of the seven technology areas currently receiving AAC support have been selected to be funded by NHS England through the Innovation and Technology Payment programme (ITP). The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products.</p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
question first answered
less than 2019-07-02T16:07:33.677Zmore like thismore than 2019-07-02T16:07:33.677Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134020
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether all products considered by the Accelerated Access Collaborative will have to be cost-neutral to the NHS. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268508 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>As it continues to drive forward the assessment and uptake of the best products for support, the Accelerated Access Collaborative (AAC) has been empowered to be flexible and pragmatic enough to identify truly game-changing innovations, that may not be cost-neutral in year, but are assessed by the National Institute for Health and Care Excellence to be both clinically and cost-effective. This will allow the AAC to identify products, or classes of products, that are most likely to significantly transform care in the National Health Service.</p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
question first answered
less than 2019-07-02T16:06:04.58Zmore like thismore than 2019-07-02T16:06:04.58Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134021
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help control hospital-acquired infections. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268509 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of NHS services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
question first answered
less than 2019-07-02T16:12:48.417Zmore like thismore than 2019-07-02T16:12:48.417Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134022
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how the Accelerated Access Collaborative plans to balance its focus on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268510 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>There are no restrictions on the type of innovation that can be supported by the Accelerated Access Collaborative (AAC). Medicinal products, therapeutic technologies, devices, diagnostics, and digital technologies are eligible to receive support.</p><p>In October 2018, the AAC announced it was supporting to increased uptake and use of 12 high performing products, which span seven technology areas, in the National Health Service. Of the seven categories selected for support, two are medicines, four are diagnostic tests, and one is a device.</p><p>Further information about the products the AAC are supporting can be found at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage more like this
question first answered
less than 2019-07-02T16:06:55.223Zmore like thismore than 2019-07-02T16:06:55.223Z
answering member
4008
label Biography information for Dame Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this